title: [ISRAELI GUIDELINES FOR THE TREATMENT OF HYPERLIPIDEMIA - 2014 UPDATE].
abstract: Atherosclerosis is one of the leading causes of morbidity and mortality in the world, including in Israel. This document updates the clinical recommendations of the Israeli medical societies (The Society for Research, Prevention and Treatment of Atherosclerosis, The Israel Heart Society, The Israel Association of Family Physicians, The Israel Society of Internal Medicine) from 2012. The need for an update stems from new studies and from the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. These recommendations take into account the guidelines of leading medical organizations in the world, as well as the specific circumstances and needs of the medical system in Israel.
authors.forename: Rafael
authors.initials: R
authors.lastname: Bitzur
authors.forename: Yoseph
authors.initials: Y
authors.lastname: Rozenman
authors.forename: Shlomo
authors.initials: S
authors.lastname: Vinker
authors.forename: Dror
authors.initials: D
authors.lastname: Dikerl
authors.forename: Joseph
authors.initials: J
authors.lastname: Shemesh
authors.forename: Amnon
authors.initials: A
authors.lastname: Lahad
authors.forename: Dov
authors.initials: D
authors.lastname: Gavishl
authors.forename: Dror
authors.initials: D
authors.lastname: Harats
authors.forename: Hilla
authors.initials: H
authors.lastname: KnobLer
mesh_terms: D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000517:prevention & control / Q000523:psychology; D008078:Cholesterol, LDL / Q000097:blood*; D015438:Health Behavior; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy; D007557:Israel; D011314:Preventive Health Services / Q000458:organization & administration / Q000639:trends; D055502:Secondary Prevention / Q000379:methods / Q000639:trends
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors